PATENT CLAIM ANALYSIS

Application Number: 15905535
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "252030"]

Abstract:
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

Claim (Index 10):
The method of  claim 3 , wherein the disorder amyotrophic lateral sclerosis.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15905524', '15247429', '15247440', '15905427', '15247424']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.833350687892563
- 35 USC 102 Novelty (BERT): 0.5670927039517216
- Combined Prediction Score: 0.8067248894984789
- Mean Citation Score: 415.64204200000006
- Max Citation Score: 444.13464000000016
- Similarity Product: 412.48270449088113

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test